Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 3Sarcoma 2Lymphoid 1

Conditions

Lymphoma 16Central Nervous System Neoplasms 9Lymphoma, Follicular 5Astrocytoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Glioblastoma 4Lymphoma, Non-Hodgkin 3Glioma 3Recurrence 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Gliosarcoma 2Glioma, Subependymal 2Ependymoma 2Burkitt Lymphoma 2Brain Neoplasms 2Blast Crisis 2Triple Negative Breast Neoplasms 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Mycosis Fungoides 1Meningioma 1Medulloblastoma 1

Interventions

Psychiatric Rehabilitation 2Bortezomib 2trametinib 1sonidegib 1ribociclib 1entinostat 1carboxyamido-triazole 1Vorinostat 1Thalidomide 1Temozolomide 1Paclitaxel 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Gelclair 1Filgrastim 1Fentanyl 1Docetaxel 1Cognitive Behavioral Therapy 190Y-octreotide, DOTA-Tyr(3)- 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Meningioma × Temozolomide × Lymphoid × Clear all
NCT00544284 2013-02-15

Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

City of Hope Medical Center

Phase 1 Completed
25 enrolled
CNSLymphoidSarcoma

Astrocytoma, Brain Neoplasms, Craniopharyngioma, Ependymoma, Glioblastoma, Glioma, Lymphoma, Medulloblastoma, Meningioma, Neoplasm Metastasis, Oligodendroglioma, Pinealoma, Central Nervous System Neoplasms, Choroid Plexus Neoplasms, Neuroectodermal Tumors, Primitive, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡